plitidepsin, has a much more potent antiviral efficacy against SARS-CoV-2 than the only antiviral approved to date, conceptual image
Size: 5183px × 3638px
Location: spain
Photo credit: © felipe caparros cruz / Alamy / Afripics
License: Royalty Free
Model Released: No
Keywords: 2019-ncov, antibody, antiviral, bottle, care, clinic, clinical, corona, coronavirus, covid, covid-19, cure, dehydrodidemnin, didemnin, disease, dose, eef1a, epidemic, flu, health, hospital, immunization, infection, inhibitors, laboratory, medical, medication, medicine, ncov-2019, oxidised, pandemic, pharmaceutical, plitidepsin, prevention, prophylactic, protection, protein, pyruvate, replication, research, respiratory, sars, sars--2, therapeutic, therapy, treatment, vaccination, vaccine, viral, virus